INTRODUCTION
The pathways that control progression through the early meiotic cycle remain poorly understood in metazoans. Drosophila melanogaster provides a genetically tractable system with which to study the relationship between early meiotic progression and oocyte development. As in mammals and Xenopus, the Drosophila oocyte initiates meiosis within the context of a germline cyst (de Cuevas et al., 1997; Pepling, 2006; Pepling et al., 1999) . Drosophila ovarian cysts are produced through a series of four synchronous mitotic divisions during which cytokinesis is incomplete (de Cuevas et al., 1997; Huynh and St Johnston, 2004) . Soon after the completion of the mitotic divisions, all 16 cells enter premeiotic S phase (Carpenter, 1981) . However, only the true oocyte, which comprises one of the two cells at the center of the syncytium, remains in meiosis and goes on to produce a gamete. The other 15 cells lose their meiotic features, enter the endocycle, and develop as polyploid nurse cells. In contrast to the nurse cells, the single oocyte remains in prophase of meiosis I until it proceeds to the first meiotic metaphase late in oogenesis. The pathways that drive this complicated series of cell cycle transitions that are so critical to the development of the mature gamete remain a topic of great interest.
The missing oocyte (mio) gene was identified in a forward genetic screen for mutants affecting cell cycle regulation and oocyte differentiation in early ovarian cysts (Iida and Lilly, 2004) . In mio mutants, the oocyte enters the meiotic cycle, forms mature synaptonemal complexes and accumulates oocyte-specific markers. However, in the absence of Mio, the oocyte fate is not stably maintained. Soon after the nurse cells enter the endocycle in stage 1 of oogenesis, mio oocytes follow the nurse cells into the endocycle, lose the preferential accumulation of oocyte-specific markers and develop as pseudo-nurse cells. Thus, mio is required for the maintenance of the meiotic cycle and oocyte identity. The mio gene encodes a 975 amino acid protein that is highly conserved from yeast to humans (Iida and Lilly, 2004 ). Yet, the molecular function of mio remains elusive. Here, we demonstrate that Mio associates with the conserved nucleoporin Seh1 (also known as Nup44A in Drosophila). Moreover, we define a tissue-specific requirement for Seh1 during oogenesis.
Seh1 is a component of a nucleoporin subcomplex known as the Nup107-160 complex in higher eukaryotes and the Nup84 complex in yeast (Fahrenkrog et al., 2004; Hetzer et al., 2005; Wozniak et al., 2010) . The Nup107-160 complex, which is the major structural component of the nuclear pore complex (NPC), consists of at least nine subunits in higher eukaryotes and functions in the regulation of mRNA export as well as in the assembly and distribution of NPCs within the nuclear envelope (Hetzer et al., 2005; Wozniak et al., 2010) . Studies over the last five years have defined several physiological functions for the Nup107-160/Nup84 complex that appear to be independent of nucleocytoplasmic transport (Fahrenkrog et al., 2004; Wozniak et al., 2010) . Most notably, in Xenopus egg extracts and HeLa cells, the Nup107-160 complex has a dynamic localization during the cell cycle (Hetzer et al., 2005) . Although present on the nuclear envelope in interphase, the entire complex targets to kinetochores, spindles and spindle poles to varying extents during mitosis (Loiodice et al., 2004; Orjalo et al., 2006) . Consistent with a mitotic function, depleting components of the Nup107-160 complex results in cell cycle abnormalities, including defects in mitotic spindle formation, chromosome segregation and cytokinesis (Orjalo et al., 2006; Platani et al., 2009) . Moreover, recent evidence indicates that in HeLa cells and Xenopus egg extracts, the Nup107-160 complex mediates microtubule nucleation at kinetochores via its interaction with the -TuRC complex (Mishra et al., 2010) . Unlike in other metazoans, in Drosophila Nup107 fails to localize to kinetochores at mitosis but is found concentrated in the spindle region (Katsani et al., 2008) . In summary, the Nup107-160 complex is multifunctional, with roles in both nucleocytoplasmic transport and cell cycle regulation.
Here, we demonstrate that Mio, a protein that is required for maintenance of the meiotic cycle and oocyte fate during oogenesis, associates with the structural nucleoporin Seh1. Surprisingly, we find that a seh1 deletion allele is viable but exhibits dramatically reduced female fertility. Closer examination reveals that, as is observed in mio mutants, in a fraction of seh1 ovarian cysts oocytes fail to maintain the meiotic cycle and oocyte fate into later stages of oogenesis. From our studies we conclude that Seh1 has an essential germline function during oogenesis but is not required for the growth or development of somatic tissues.
MATERIALS AND METHODS

Drosophila strains and genetics
The mio 1 and mio 2 alleles were described previously (Iida and Lilly, 2004) .
The Drosophila stock carrying the PBac{WH}f07552 insertion was obtained from the Harvard Exelixis Collection (Thibault et al., 2004) . The Drosophila stock carrying the insertion P{RS3}Nup44A CB-0750-3 was obtained from the Szeged Stock Center (Ryder et al., 2004) . All additional stocks were provided by the Bloomington Stock Center or were generated as described below.
Generation of seh1 deletion
A flipase recognition target (FRT) site-directed recombination was conducted to generate a deletion encompassing seh1 coding sequence (CDS) using the Drodel Deficiency Kit (Bloomington Stock Center). The strains used were f07552a and CB-0750-3, each carrying single transposon insertions containing FRT sites located in the first intron and at the 3Ј end of seh1 (see Fig. S1 in the supplementary material). The FRT recombination was carried out as described (Golic and Golic, 1996) . Two seh1 deletions were generated: seh1 15 and seh1 86 . The deletions were characterized by sequencing the FRT junction site and by PCR amplification of the seh1 gene region in both the deleted and parental strains (data not shown). As predicted by the genome location of the transposons, we verified that the recombination generated a deletion of 2775 bp (from 3,876,949 to 3,879,724 bp) that includes the full seh1 CDS (see Fig. S1 in the supplementary material). The described stocks are also referred to as w
1118
; seh1
15
/SM6a and w
1118
86
/SM6a and represent null alleles of seh1. DNA oligos (5Ј to 3Ј) for FRT junction analysis were: W11678u, TCATCGCAGATCAGAAGCGG; W5662-81, GTCTGGCCA -TTCTCATCGTGA; P{WH}3984-3959, TAATTCGGCTGCTGCTCTA -AA CG ACG; and P{WH}4434-4409, CGTTTCGTAGTTGCTCTTT -CGCTGTC.
cDNA and constructs
The full-length mio CDS was cloned in frame with a 5Ј 1ϫ FLAG and a 3Ј HA tag into a pCRII-Topo vector (Invitrogen, Carlsbad, CA, USA) and subcloned into the pCaSpeR4 vector (EMBL Accession Number, X81645) downstream of a 1061 bp fragment encompassing the native mio promoter region.
The full-length cDNA SD07614 encoding the seh1 gene was obtained from the Drosophila Genomics Resource Center (Indiana University, Bloomington, IN, USA).
The CDS of the Drosophila seh1 gene was amplified by two consecutives PCR rounds to add a 5Ј1ϫ FLAG and 3ЈHA tag and the unique restriction sites KpnI and XhoI at the 5Ј end and NotI and HindIII at the 3Ј end using the following sets of primers (5Ј to 3Ј): NUP1Ff, AGGAGGGTACCCTCGAGATGGTCGACGTGGAACCC; NUP1Rv, GGTAAAGCTTTGCGGCCGCGTGCCACGGCACCTGGT; NUP2Ff, GACCATGGATTACAAGGATGATGATGATAAGGAGGGTACCCTCG -AG; and NUP2Rv, TCTAGAAGCATAATCAGAACATCATAAGGGT -AAAGCTTTGCGGCC. The PCR product was subcloned into the pTOPO Blunt cloning vector (Invitrogen) and sequenced.
The construct FLAG::seh1::HA was subcloned into the multiple cloning site (MCS) of the expression vector pAct5C (Krasnow et al., 1989) under the control of the promoter of the Drosophila Act5C gene.
The Cerulean (CeFP) CDS was amplified from the pCerulean-C1 vector (Clontech, Mountain View, CA, USA) using the following primers: CeFPFf, GCTAGCGCTACCGGTCGCCACCGGTCGCCACCAT; and CeFPRv, GTTATCTAGATCCGGTGGATCCCGGGCCCGCGGTA. The PCR product was cloned into the pTOPO Blunt vector, sequenced and further subcloned into the MCS of pAct5C in frame with the seh1::HA sequence.
CeFP::seh1::HA sequence was subcloned into the MCS of the vector pUASp (Rorth, 1998) using the unique restriction sites BamHI and XbaI.
The mCherry CDS was amplified from the pmCherry-C1 expression vector (Clontech) using the following primers: mCherryATG, gccgGAATTCatggtgagcaagggcgaggaggata; and mCherry Rev, gccgGAATTCttacttgtacagctcgtccatgccgc. The PCR product was subcloned into pAct5C in frame with the construct seh1::HA.
P element-mediated transformation and rescue
The construct p{w 1118 , UAS::CeFP::seh1::HA} was injected into a white background to generate transgenic flies (Duke University Model System Genomics Service, Durham, NC, USA). To rescue the seh1 genetic defects, the CeFP::seh1::HA construct was expressed in the seh1 15 null genetic background using the germline-specific driver nanos-Gal4::VP16 (Rorth, 1998) .
Generation of Mio antibody
The full-length mio CDS was cloned into the MCS of the bacterial expression vector pET32a (Novagen) and expressed in E. coli BL21 cells. The protein was purified from bacterial inclusion bodies according to standard techniques and the antigen was used to produce rabbit Mio antiserum (Covance, Princeton, NJ, USA). The Mio antiserum was used for western blot analysis in the present study.
S2 cell culture and RNA interference
S2 cells were grown in ventilated plastic flasks in Schneider's Drosophila medium (Gibco-Invitrogen) supplemented with 10% inactivated fetal bovine serum at 25°C. RNA interference (RNAi) was carried out as described (Maiato et al., 2003) . The double-stranded (ds) DNA transcription was carried out using the MEGAscript T7 RNAi Kit and the dsRNA was purified using the MEGAclear Kit (Ambion-Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocols. The RNAi templates were generated by PCR amplification using the following primers: MioRNAiFf, taatacgactcactatagggATGAGCGGCAATACACACGGACTCA; MioRNAiRv, taatacgactcactatagggGGCCGTCTCCTTGGGAACTCC; NupRNAi#1Ff, taatacgactcactatagggagaCGACGTGGAACCCATTATTG; NupRNAi#1 Rv, taatacgactcactatagggagaTGTTGCTAATCTCGTGCTGC; NupRNAi#3Ff, taatacgactcactatagggagaGCAGCACGAGATTAGCAACA; NupRNAi#3Rv, taatacgactcactatagggagaTAGTTCATTCGCCACAGACGC; GFPRNAiFf, taatacgactcactatagggagaTGAGCAAGGGCGAGGAGCTGTTCAC; and GFPRNAiRv, taatacgactcactatagggagaAGTTGTACTCCAGCTTGTGCCCCAG.
Immunostaining and imaging
Fixation and immunostaining of ovaries were performed as described (Grieder et al., 2000) . Antibodies were used at the following dilutions: mouse anti-Orb 6H4, 1:100 (purified IgG, Developmental Studies Hybridoma Bank, University of Iowa, IA, USA); mAb414, 1:400 (Covance); mouse anti-GFP, 1:200 (Roche, Basel, Switzerland); mouse anti-Mtor, 1:100 (Qi et al., 2004) ; rabbit anti-dmNup153, 1:200 (Dimaano et al., 2001) ; and rabbit anti-dmNup107, 1:1000 (Katsani et al., 2008) . Secondary antibodies were anti-rabbit and anti-mouse conjugated to Alexa Fluor 594 and Alexa Fluor 488 (Molecular Probes-Invitrogen) and used at 1:1000. Nuclei were visualized by staining the DNA with DAPI (SigmaAldrich, St Louis, MO, USA). Images were acquired using an Olympus FV1000 Fluoview laser-scanning confocal microscope (Olympus, Tokyo, Japan). Composite figures were prepared using Photoshop 7.0 and Illustrator (Adobe Systems, San Jose, CA, USA).
In situ hybridization
In situ hybridization was carried out as described (Tautz and Pfeifle, 1989) . Sense and antisense probes were dUTP-Dig labeled by asymmetric PCR amplification of the fourth exon, which is common to all of the predicted transcripts, using the following primers: Seh1 Sense, GACGCC -ACGGACATCTCCAAG; and Seh1 Anti, TGCCACG GCACCT -GGTTGCCG.
Tandem affinity purification and mass spectrometry
Drosophila S2 cells were stably or transiently transfected with a plasmid expressing full-length mio tagged with FLAG and HA under the control of a 1061 bp region of the wild-type mio promoter. One liter of S2 cell culture was used for a large-scale tandem affinity purification protocol using the FLAG HA Tandem Affinity Purification Kit (Sigma-Aldrich) according to the manufacturer's instructions. A modified RIPA buffer was used for the extraction (see below). One liter of untransfected S2 culture was used as control. The immunopurified samples were loaded on a 4-12% SDS gradient gel (Invitrogen) and stained with Coomassie Blue; the visible bands were excised and analyzed by tandem mass spectrometry (MS/MS; Custombiologics, Ontario, Canada).
Western analysis
Proteins from ovaries or S2 cells were extracted in modified RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5% sodium deoxycholate, 1.0% Nonidet P40, 0.4 mM EDTA) containing 1 mM PMSF and Protease Inhibitor Cocktail (Roche). The supernatants were resolved in a NuPage 4-12% polyacrylamide gradient gel (Invitrogen) and blotted onto a PVDF membrane using a semi-dry Trans-Blot system (BioRad, Hercules, CA, USA). Western blot analyses were carried out using standard techniques. Mio antiserum was used at 1:10,000, mouse anti--tubulin (Jackson ImmunoResearch) at 1:5000, mouse anti-GFP (Roche) at 1:3000 and anti--actin (AbCam) at 1:1000. Anti-mouse and anti-rabbit horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) were used at 1:5000 and 1:10,000, respectively.
RESULTS
Mio interacts with the nucleoporin Seh1
To identify proteins that physically interact with Mio, we performed a large-scale immunoprecipitation of a tagged HA-Mio-FLAG protein from Drosophila Schneider 2 (S2) tissue culture cells (Fig.  1A ). Tandem mass spectrometry was employed to analyze the immunoprecipitated proteins. From several independent experiments, one protein, the nucleoporin Seh1, consistently co-purified with Mio. Seh1 is a component of the Nup107-160 subcomplex (Loiodice et al., 2004) . Intriguingly, Seh1 was the only nucleoporin identified in any of our immunoprecipitations of Mio. Moreover, we determined by western blot that Mio does not co-immunoprecipitate the nucleoporins Nup107 and Mtor (also known as Tpr) (data not shown). In the Drosophila genome, the Nup44A gene encodes the only homolog of seh1; we will refer to the Nup44A gene and Nup44A protein as seh1 and Seh1.
Consistent with a role for Seh1 in oogenesis, in situ hybridizations demonstrate that seh1 is transcribed in developing ovarian cysts (Fig. 1B) . Additionally, microarray analysis indicates that seh1 is transcribed at moderate levels in nearly all tissues (Chintapalli et al., 2007) . In order to determine the subcellular localization of the Seh1 protein, we generated a transgenic line that expressed a tagged Seh1 protein under the control of an inducible promoter (UASp::CeFP::Seh1::HA). As described below, the CeFP-Seh1-HA protein is fully functional as measured by the ability of the transgene to rescue a seh1 null allele. As anticipated for a nucleoporin, when expressed in the female germline CeFP-Seh1-HA was enriched on the nuclear envelope of the nurse cells and oocyte (see Fig. S2 in the supplementary 2135 RESEARCH ARTICLE Seh1 functions in oogenesis (A)Immunoprecipitation from S2 whole-cell lysates. Drosophila S2 cells were stably transfected with a vector containing FLAG-and HA-tagged mio coding sequence under the control of the wild-type mio promoter. Immunoprecipitates were run on an SDS-PAGE gel and stained with Coomassie Blue. The sample was compared with immunoprecipitates from non-transfected S2 cells (control ). Tandem mass spectrometry was used to identify the co-precipitated proteins. Mio and Seh1 are indicated. (B)To verify the expression of seh1 in the Drosophila germline, wild-type ovaries were labeled with antisense and sense seh1 digoxigenin probes consisting of the seh1-RB fourth exon. Asterisk denotes the germarium. (C)Seh1 and Mio interact in the Drosophila germline. Immunoprecipitates are shown of total protein extracts from Drosophila ovaries expressing Seh1 under the control of the nanos-Gal4 driver. The immunoprecipitation was performed using an anti-GFP monoclonal antibody to pull down CeFP-Seh1-HA tagged protein. The immunoprecipitation of Seh1 was evaluated by western blot using antibodies against the HA tag. The levels of Mio protein were examined in total protein extracts (T), supernatant (S) and immunoprecipitated pellet (P). The control immunoprecipitation was performed using purified isotype-matched mouse IgG. material). Similarly, the CeFP-Seh1-HA protein localized to the nuclear envelope in syncytial embryos as well as in somatically derived S2 tissue culture cells (see Fig. S2 in the supplementary material; data not shown). However, unlike the behavior of Seh1 in Xenopus and mammals, in Drosophila CeFP-Seh1-HA did not accumulate on kinetochores in mitosis (data not shown). The absence of detectable levels of Seh1 at kinetochores is consistent with the pattern of localization reported for another Drosophila component of the Nup107-160 complex, Nup107 (Katsani et al., 2008) . Finally, we confirmed that Mio and Seh1 interact in the female germline. We expressed the CeFP-Seh1-HA protein in the female germline by means of the nanos-Gal4 driver. An anti-GFP antibody was used to immunoprecipitate the CeFP-Seh1-HA protein. In this experiment, endogenous Mio protein coprecipitated with CeFP-Seh1-HA (Fig. 1C) . Together, our data indicate that Mio associates with the nucleoporin Seh1 in both germline and somatic tissues.
Seh1 is required for oogenesis but is dispensable for somatic development
To fully assess the role of Seh1 in vivo we generated a seh1 null allele. seh1 is predicted to encode three transcripts of 2401 nt (seh1-RA), 1284 nt (seh1-RB) and 1332 nt (seh1-RC) (FBgn0033247). All three predicted transcripts contain the same open reading frame (ORF), which encodes a protein of 354 amino acids (see Fig. S1 in the supplementary material). To generate a seh1 null allele we made a 2775 bp deletion that removes the entire seh1 ORF (see Materials and methods for details). The deletion does not extend into adjacent genes (see Fig. S1 in the supplementary material). Two independent isolates of the seh1 deletion, seh1
15 and seh1
86
, were generated. The phenotypes of the independent seh1  isolates were indistinguishable. For the majority of the studies described here, we used the seh1 15 deletion. Surprisingly, seh1 15 mutants were homozygous viable and eclosed at nearly Mendelian ratios. However, seh1
15
homozygous females exhibited markedly reduced fecundity, laying just one-quarter the eggs of wild-type controls. Moreover, the eggs laid by seh1 15 females hatched at ~40% of the rate of those laid by age-matched wild-type controls (n>280). Importantly, the reductions in seh1 15 fertility, as well as the specific oogenesis defects described below, were rescued when the tagged seh1 transgene was expressed using the germline-specific driver nanosGal4. Thus, the fertility defects observed in seh1 15 females are due to the absence of the seh1 gene product in the germline.
The Drosophila ovary comprises 16-20 ovarioles. Individual ovarioles are composed of a germarium, which contains germline and somatic stem cells, followed by a series of egg chambers at successively older stages of development. The germarium, which is present at the anterior tip of the ovariole, is divided into three regions. In region 1 (R1), incomplete mitotic divisions result in the production of the 16-cell interconnected germline cyst. Individual cells within the ovarian cyst are referred to as cystocytes. In region 2a (R2a), all 16 cells enter meiosis and undergo premeiotic S phase. Subsequently, in late R2a, a meiotic gradient forms as the cells near the center of the cyst, construct synaptonemal complexes and accumulate oocyte markers. As cysts progress down the germarium into region 2b (R2b) and beyond, the meiotic cycle is restricted to the single oocyte. Finally, in region 3 (R3), just prior to when the fully formed egg chamber buds off from the germarium, the nurse cells enter the endocycle while the oocyte remains in prophase of meiosis I.
To better understand the role of seh1 in oogenesis, we labeled seh1 15 and wild-type ovaries with several markers that allowed us to follow oocyte development and meiotic progression. Mutant and wild-type ovaries were dissected, fixed and stained with DAPI and with antibodies against Orb, a germline-specific protein that is expressed at high levels in post-mitotic ovarian cysts, and against -Spectrin, a component of the actin cytoskeleton (de Cuevas et al., 1996; Lantz et al., 1994; Page and Hawley, 2001) . Consistent with reduced fertility, seh1 15 ovarioles contained fewer egg chambers and exhibited smaller germaria than ovarioles from wildtype females (Fig. 2) . To follow the mitotic cyst division in R1 of the germarium, we examined fusome morphology. The fusome is a germline-specific organelle, rich in actin cytoskeletal proteins, that forms along the remnants of the mitotic spindles to connect all cells within mitotically active ovarian cysts (de Cuevas et al., 1997; McKearin, 1997) . The branching pattern of this unique germline organelle can be used to identify ovarian cysts in the mitotic cycle (de Cuevas et al., 1996; de Cuevas and Spradling, 1998; Grieder et al., 2000; Lin et al., 1994) . Analysis of fusome morphology in seh1 15 germaria using anti--Spectrin revealed that the number and distribution of RESEARCH ARTICLE Development 138 (10) Table 2 ). Thus, seh1 influences oocyte development. Intriguingly, failure to maintain the meiotic cycle and oocyte identity is the primary phenotype observed in mio ovaries (Iida and Lilly, 2004) . We wanted to determine whether seh1 ovarian cysts fail to enter the meiotic cycle in the germarium or, alternatively, if mutant oocytes enter meiosis but fail to maintain the meiotic cycle into later stages of oogenesis. In order to distinguish between these two possibilities, we followed meiotic progression using an antibody against the synaptonemal complex protein C(3)G (Page and Hawley, 2001) . As is observed in both wild-type and mio egg chambers, seh1 ovarian cysts entered the meiotic cycle with a fraction of cystocytes progressing to pachytene, as measured by the construction of a mature synaptonemal complex (Fig. 3E,F) . However, in ~20% of seh1 egg chambers, the oocyte failed to maintain the meiotic cycle and instead entered the endocycle and developed as a pseudo-nurse cell (Fig. 3B,D) . Thus, mutations in seh1 disrupt the ability of the oocyte to maintain the meiotic cycle beyond the germarium.
Maintenance of the meiotic cycle and oocyte identity require the directional transport of proteins and mRNAs from the nurse cells to the oocyte along a polarized microtubule network (reviewed by Huynh and St Johnston, 2004) . We examined the distribution of the Orb protein in wild-type and seh1 developing ovarian cysts. During the early meiotic cycle, the distribution of Orb is dynamic (Christerson and McKearin, 1994; Lantz et al., 1994) . In wild-type ovarian cysts, Orb localization starts out relatively homogenous in R2a. However, as cysts travel down the germarium the Orb protein accumulates in a single centrally localized cell, such that by late R2b, high levels of Orb are restricted to the anterior cortex of the presumptive oocyte. Subsequently, in R3, just prior to when the egg chambers bud off from the germarium, the focus of Orb staining follows the microtubule-organizing center (MTOC) and translocates from the anterior to the posterior of the oocyte. We found that in over 25% of seh1 15 ovarian cysts (n>128), the preferential accumulation of Orb to the oocyte was delayed and/or otherwise aberrant. Additionally, in seh1 mutants the focus of Orb staining often failed to translocate to the posterior of the oocyte in R3, with older egg chambers retaining an anterior localization of Orb (see Fig. S3 in the supplementary material). The dynamic localization of Orb during oogenesis requires a polarized network of microtubules to be established and maintained in developing ovarian cysts (Theurkauf et al., 1993) . Thus, our data suggest that the regulation of microtubule dynamics and/or function might be aberrant in a fraction of seh1 15 ovarian cysts.
An additional marker for the regulation of microtubule organization and function in ovarian cysts is the dynamic behavior of the nurse cell centrioles in R2 and R3 of the germarium. After completion of the mitotic cyst divisions, the nurse cell centrioles dissociate from the nuclear membrane and migrate along the fusome towards the oocyte (Mahowald and Strassheim, 1970) . By R3, most of the centrioles have completed this migration and are located in a loose cluster near the anterior of the oocyte nucleus. Subsequently, the centrioles migrate to the newly formed MTOC near the posterior of the oocyte (Huynh et al., 2001b; Huynh and St Johnston, 2004) (Fig. 4A) . We found that in a fraction of seh1 15 egg chambers, the centrioles failed to undertake this essential migration (Fig. 4B) . By examining older seh1 15 egg chambers, we observed that the failure of centrioles to migrate correlates with entry into the endocycle and the loss of the oocyte fate. Similarly, in mio egg chambers the centrioles failed to undertake this crucial migration (Fig. 4C) . Taken together, these data suggest that Seh1 might influence the maintenance of the meiotic cycle and oocyte identity by regulating the construction and maintenance of the polarized microtubule network within the developing oocyte. Consistent with this hypothesis, in seh1 and mio egg chambers the distribution of microtubules was frequently disorganized, with mutant egg chambers lacking the posterior accumulation of microtubules that marks the MTOC in wild-type egg chambers ( Fig. 4D-F) . In mammalian cells, reducing the levels of Seh1, or other Nup107-160 complex members, results in spindle defects and mitotic delay (Mishra et al., 2010; Platani et al., 2009; Zuccolo et al., 2007) . Additionally, Xenopus egg extracts depleted of Nup107-160 complex members have a reduced ability to assemble bipolar spindles (Mishra et al., 2010; Orjalo et al., 2006) . Therefore, we examined whether mutations in seh1 alter mitotic progression during oogenesis, which might partially account for the reduced fecundity of seh1 15 females, by staining seh1 15 and wild-type ovaries with antibodies against Histone H3 phosphorylation at serine 10 (PH3), which serves as a marker for cells in mitosis (Hendzel et al., 1997) . We counted the number of germaria that contained at least one PH3-positive ovarian cyst in R1. Although seh1 15 and wild-type germaria had similar numbers of ovarian cysts in R1, in seh1 15 germaria about twice as many ovarian cysts were positive for PH3, indicating that they spend a greater proportion of their time in mitosis: 43.1±3.9% (n117) of seh1 15 germaria versus 20.7±7.1% (n168) of wild-type germaria had at least one PH3-positive cyst (P<0.001). Thus, seh1 mutants exhibit a mitotic delay during the ovarian cyst divisions.
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Seh1 promotes the accumulation of Mio protein
We analyzed the levels of Mio in total protein extracts from wildtype and seh1 ovaries by western blot (Fig. 5A ). Mio protein levels were reduced in ovarian extracts in two independent seh1 mutant backgrounds: the null allele seh1 15 and the hypomorph seh1
EP2417
. Notably, the decrease in Mio protein levels in the extracts from seh1 15 mutants was significantly greater than that observed with the hypomorphic seh1 allele (Fig. 5) . Consistent with the western blot analysis, immunostaining revealed that the levels of Mio protein were reduced and/or dispersed in seh1 15 ovarian cysts (data not shown). Finally, targeting the seh1 transcript using two different RNAi constructs in S2 tissue culture cells dramatically reduced the levels of Mio protein (Fig. 5B) . Specifically, 48 hours after targeting the seh1 transcript by RNAi, the level of Seh1 and Mio proteins were decreased in both seh1 RNAi samples relative to mock-treated cells. From these data, we conclude that Seh1 promotes the accumulation of Mio in both germline and somatic tissues of Drosophila. Although the loss of Seh1 reduced Mio protein levels, overexpression of Seh1 was not sufficient to increase the levels of Mio protein (see Fig. S4 in the supplementary material). These data indicate that Seh1 is necessary but not sufficient for the accumulation of Mio.
seh1 suppresses the mio 16-nurse-cell phenotype To better define the relationship between mio and seh1, we examined whether the genes interact genetically. Surprisingly, we found that seh1 acts as a strong dominant suppressor of mio. Specifically, the percentage of mio mutant egg chambers with an oocyte increased 6-fold when a single copy of the seh1 15 allele, or a larger deletion of the seh1 genomic region, was present in the mio mutant background (Table 2 and Fig. 6D ). Indeed, even a single copy of the seh1 EP2417 hypomorphic allele partially suppressed the mio phenotype. In mio single mutants, the vast majority of egg chambers arrested prior to stage 5 of oogenesis, well before the
RESEARCH ARTICLE
Development 138 (10) and mio 2 (C,F) Drosophila egg chambers stained with anti-C(3)G (red) and anti--Tubulin (green) to mark centrioles (A-C, arrows). Egg chambers in D-F are stained with anti-C(3)G (red) and anti--Tubulin (green) to mark microtubules. Note that in seh1 15 (B) and mio 2 (C) egg chambers, the centrioles fail to migrate to the posterior of the oocyte. In wild-type egg chambers (D), microtubules accumulate in a crescent at the posterior of the oocyte (arrowhead). This posterior accumulation is often lacking in oocytes from seh1 (E) and mio (F) egg chambers.
start of vitellogenesis in stage 7 (Fig. 6C) (Iida and Lilly, 2004) . By contrast, egg chambers from mio, seh1/mio,+ females frequently progressed through vitellogenesis to produce mature eggs (Table 2 and Fig. 6D ). Moreover, a small percentage of the eggs laid by mio, seh1 15 /mio,+ females hatched and developed into viable adults.
Interestingly, reducing the dose of mio did not affect the ovarian phenotype of seh1 (data not shown). Finally, we found that ovaries from mio 2 , seh1 15 females closely resembled those from seh1 15 single mutants, with 80% of egg chambers containing an oocyte and 20% containing 16 nurse cells and no obvious oocyte (Table  2) . These data strongly suggest that seh1 is epistatic to mio with respect to the 16-nurse-cell phenotype. However, we note that ovaries from mio 2 , seh1 15 double homozygotes have fewer older egg chambers than seh1 15 single mutants, suggesting that mio might have functions that are independent of seh1.
Mtor distribution is altered in seh1 early meiotic cysts In mammalian tissue culture cells, reducing the levels of Seh1 results in the partial redistribution of multiple nucleoporins from the NPC to cytoplasmic foci (Cordes et al., 1997; Loiodice et al., 2004) . In order to determine whether Seh1 directs the recruitment of nucleoporins to the NPC in Drosophila, we examined the subcellular distribution of Nup107, Nup153 and Mtor, as well as the Phe-Gly (FG) repeat-containing nucleoporins in seh1 mutant ovaries (Katsani et al., 2008; Mendjan et al., 2006; Qi et al., 2004) . Notably, in both the somatic and germline cells of seh1 mutant ovaries, the distribution of Nup107, a core component of the Nup107-160 complex, was indistinguishable from that of the wild type in both germline and somatic tissues (Fig. 7D,E) . Similarly, the distribution of the FG-containing nucleoporins, which line the inner channel of the NPC, as well as that of Nup153 appeared unaffected in the seh1 background ( Fig. 7F,G ; data not shown). Moreover, we determined that Mio does not co-immunoprecipitate Nup107, Nup153 or Mtor (data not shown). Thus, as suggested by our phenotypic analysis as well as by work in other organisms, Seh1 does not play a major role in the recruitment of nucleoporins to the NPC. Although Mio does not physically associate with the nucleoporin Mtor, we found that mutations in seh1 alter the distribution of Mtor in the female germline, most notably as cysts enter the meiotic cycle beginning in R2a of the germarium (Fig. 6B,C ; data not shown). In interphase cells, Mtor is found on the inner face of the NPC in a structure called the nuclear basket, as well as in the nucleoplasm (Krull et al., 2004; Hase and Cordes, 2003) . In wildtype females, Mtor has an interphase-like distribution in ovarian cysts in R2a, R2b and R3 of the germarium (Fig. 7A) . However, in seh1 ovarian cysts, there was a 20% displacement of Mtor from the nuclear envelope to the nucleoplasm ( Fig. 7 and see Fig. S5 in the supplementary material). Thus, mutations in seh1 alter the distribution of the nucleoporin Mtor during the early meiotic cycle in Drosophila females.
DISCUSSION
Here, we demonstrate a surprising tissue-specific requirement for the structural nucleoporin Seh1 in the female germline. We show that Seh1 associates with Mio, a highly conserved protein that is required for maintenance of the meiotic cycle and oocyte identity in Drosophila. Like mio, seh1 has a crucial germline function during oogenesis. Moreover, our characterization of a seh1 null allele indicates that, although required in the female germline, seh1 2139 RESEARCH ARTICLE Seh1 functions in oogenesis Two independent seh1 RNAi targets were used, both of which reduced Mio protein levels compared with the control, which employed a sequence directed against GFP. is dispensable for the development of somatic tissues. Our work represents the first examination of seh1 function within the context of a multicellular organism.
To better understand how Mio influences the maintenance of the meiotic cycle and oocyte fate in Drosophila, we identified proteins that co-purify with Mio by tandem affinity purification. From these experiments, we determined that Mio is present in a stable complex with the structural nucleoporin Seh1. Seh1 is a component of the Nup107 complex, which is the primary structural unit of the nuclear pore. Studies in multiple organisms indicate that, although Seh1 is a nucleoporin, it is not required for bulk nucleocytoplasmic transport and has a limited role in the localization of other nucleoporins to the NPC (Loiodice et al., 2004; Orjalo et al., 2006) . In contrast to its limited role at the NPC during interphase, recent evidence indicates that Seh1 has an essential function during mitosis. In Xenopus egg extracts and mammalian tissue culture cells, a fraction of the Nup107 complex that includes Seh1 targets to kinetochores, spindles and/or spindle poles from early prometaphase through early anaphase (Belgareh et al., 2001; Orjalo et al., 2006) . Moreover, reducing the levels of Nup107-160 components disrupts spindle assembly and cytokinesis (Aitchison et al., 1995; Bai et al., 2004; Mishra et al., 2010; Orjalo et al., 2006; Platani et al., 2009; Zuccolo et al., 2007) . Importantly, the specific depletion of seh1 results in the failure of the Nup107 complex to target to kinetochores at mitosis and results in multiple mitotic defects (Zuccolo et al., 2007; Platani et al., 2009 ). Thus, Seh1 plays a role in the construction and/or maintenance of bipolar spindles in multiple organisms.
To define the role of Seh1 in Drosophila we generated a seh1 null deletion allele. Considering the key role of Seh1 during mitosis in other organisms, we were surprised to find that seh1 null homozygotes are viable. From this observation we conclude that seh1 is dispensable in Drosophila for the mitotic cycle during the majority of somatic divisions. Consistent with a limited role for Seh1 during the mitotic cycle, we did not observe the specific accumulation of Seh1 on kinetochores during mitosis. Although this might reflect a limitation of our reagents, these data are in agreement with previous work demonstrating that the core component of the Nup107-160 complex, the nucleoporin Nup107, fails to accumulate at kinetochores during mitosis in multiple Drosophila tissues (Katsani et al., 2008) . Our studies also suggest a limited and/or redundant role for Seh1 in supporting the general structure and/or function of the NPC in interphase cells. Specifically, we find that multiple nucleoporins, including Nup107, target to the NPC in the absence of Seh1 in both germline and somatic tissues. The only nucleoporin mislocalization observed in seh1 null mutants involved a limited displacement of
Mtor from the nuclear envelope to the nucleoplasm in meiotic cysts in the germarium. Mtor is a component of the nuclear basket and is present on the cytoplasmic face of the NPC during interphase but relocates to the spindle matrix during mitosis (Lince-Faria et al., 2009; Qi et al., 2004) . Whether the partial displacement of Mtor in the seh1 background reflects a direct role for Seh1 in recruiting and/or stabilizing Mtor at the NPC remains to be determined. Although dispensable for somatic development, we find that seh1 has an essential function in the female germline during oogenesis. seh1 null females are nearly sterile, producing only a small number of adult progeny. Indeed, seh1 null females lay fewer eggs and contain ovarioles with a diminished number of egg chambers relative to wild-type females. A possible contributory factor to this reduced egg production is the mitotic delay observed during the ovarian cyst divisions. We find that in ovaries from seh1 females, stem cells and ovarian cysts in R1 of the germarium spend a greater proportion of their time in mitosis than those in wild-type females. This phenotype is consistent with the metaphase delay observed in mammalian cells and Xenopus egg extracts depleted of members of the Nup107-160 complex, including Seh1. Thus, mutations in seh1 alter the rate of egg chamber production, as well as the nature of the ovarian cyst divisions in the germarium. In addition to affecting the overall rate of egg production, Seh1 influences the differentiation of the oocyte within the ovarian cyst. We demonstrate that, similar to what is observed in mio mutants, in a fraction of seh1 ovarian cysts the oocyte enters the endocycle and develops as a pseudo-nurse cell. This does not reflect an inability of seh1 null oocytes to enter the meiotic cycle. On the contrary, seh1 null ovarian cysts enter the meiotic cycle on schedule with the two pro-oocytes progressing to pachytene, as measured by the construction of a mature synaptonemal complex. However, soon after exiting the germarium, a fraction of seh1 mutant oocytes enter the endocycle and become polyploid. In Drosophila, oocyte differentiation, as well as the maintenance of the meiotic cycle, are contingent on the microtubule-based transport of mRNAs and proteins from the nurse cells to the oocyte (Huynh and St Johnston, 2004) . The germline-specific RNA-binding protein Orb starts to accumulate in the oocyte in late R2a of the germarium. Defects that impair the microtubule-dependent accumulation of Orb in the oocyte correlate with the inability to maintain the meiotic cycle through later stages of oogenesis (Cox et al., 2001a; Cox et al., 2001b; Dienstbier et al., 2009; Fichelson et al., 2010; Hong et al., 2003; Huynh et al., 2001a; Huynh et al., 2001b; Huynh and St Johnston, 2000; Navarro et al., 2004; Roper and Brown, 2004) . We find that in seh1 ovarian cysts, the specific accumulation of Orb in the oocyte, as well as the secondary migration of Orb protein from the anterior to the posterior of the oocyte, are often delayed and/or otherwise defective. Additionally, the microtubule-dependent translocation of centrioles from the anterior to the posterior of the oocyte nucleus in the stage 1 oocyte is defective in both mio and RESEARCH ARTICLE Development 138 (10) seh1 ovarian cysts. Thus, as is observed with mio, seh1 influences the ability of the oocyte to maintain the meiotic cycle and oocyte fate beyond the germarium. As Seh1 has been implicated in a variety of cellular functions, there are several possibilities as to how it might influence oocyte development and meiotic progression. First, Seh1 might act at the NPC to regulate the nucleocytoplasmic transport of specific molecules required for oocyte differentiation and growth. Second, Seh1 might regulate the activity of Mtor and/or other nucleoporins that have recently been implicated in transcriptional regulation (Vaquerizas et al., 2010) . Finally, consistent with the alterations in mitotic cyst division and Orb localization, Seh1 might directly influence the organization and/or function of microtubules within ovarian cysts. Currently, we favor the third model because it is the most congruent with previous observations on the role of Seh1 in other organisms as well as with our own data.
We have shown that Mio and Seh1 are present in a stable complex and that both proteins are dispensable for somatic development but are required for the development of the mature egg. Additionally, we find that Seh1 is required for Mio protein stability. In the seh1 mutant background, Mio protein levels are reduced dramatically. Furthermore, depleting seh1 via RNAi in S2 tissue culture cells results in a rapid reduction in Mio protein levels. These results suggest the following simple model. Seh1 influences oocyte growth and the maintenance of the oocyte fate through its ability to promote the stability of the Mio protein. In the absence of Seh1, Mio protein levels fall, resulting in a mio-like phenotype. However, two lines of evidence suggest that Mio and Seh1 have a more complex interaction. First, overexpressing mio in the seh1 mutant background fails to rescue the seh1 phenotype. This failure to rescue is observed even though the seh1
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; UAS-mio ovaries have high levels of Mio protein in the germline. This strongly suggests that the seh1 ovarian phenotype is not due solely to the instability of the Mio protein in the absence of Seh1. Second, seh1 acts as a strong dominant suppressor of the mio 16-nurse-cell phenotype. A possible model to explain this counterintuitive result is that mio and seh1 act in opposing directions to regulate a common pathway that is crucial for the maintenance of the oocyte fate. Misregulation of this common pathway by either mio or seh1 could result in the reversion of the oocyte to the default state of nurse cell.
In the future, studies of Mio and Seh1 will help elucidate the pathways that drive oocyte development and meiotic progression and contribute to our understanding of how individual NPC components drive tissue-specific differentiation.
